A complete application in a minute
Tailored resume and cover letter, ready to send.
Cogent Scientific is seeking a Pharma Analytical Chemist to develop and validate analytical methods for RNA quantification and lipid nanoparticle analysis. The role involves LC-MS/MS method development, QC testing of LNP batches, and cross-functional data interpretation.
The ideal candidate has a BS or MS in a relevant field with 0–5 years of lab experience, strong communication, and teamwork skills. Onsite in Watertown, MA, with a day shift schedule.
Cogent Scientific, an insourced contract research organization, is looking for the right people to accomplish our Mission: to support the life sciences industry by cultivating and empowering exceptional scientists to deliver specialized laboratory services that advance research, foster collaboration, and accelerate innovation through quality and a shared commitment to excellence. We can offer you the chance to build on your skills and knowledge while working among experts in their fields and with cutting-edge instrumentation.
Cogent Scientific offers competitive pay, attractive benefits (such as medical/dental/vision insurance; 401(k); parental leave; PTO and paid holidays; etc.) and an exciting work environment. This position may include relocation benefits as well. We aim to recruit the best people who stand out among their peers and embody our Core Values:
We currently have a role available for a Pharma Analytical Chemist.
Job duties include, but are not limited to, the following:
Job requirements include, but are not limited to, the following:
This is an onsite, day shift position (approx. 8a-5p local time) at the Watertown, MA site. This role does not accommodate a remote or hybrid work schedule.
Cogent Scientific provides equal employment opportunities to all applicants and does not discriminate based on any legally protected characteristic.
Additionally, if you require a reasonable accommodation during the application or interview process, please let us know.
This job posting will close by 12/31/2026 or when a candidate is identified, whichever comes first.